English
简体中文
Total: £ 56.28
Published Date: 2025-05-27 | Pages: 142 | Tables: 144 | Medical Care
In 2024, the global market size of Depression Drugs was estimated to be worth US$ 18130 million and is forecast to reach approximately US$ 22080 million by 2031 with a CAGR of 2.9% during the forecast period 2025-2031.
Depression is a mental health issue. It’s a condition that starts most often in early adulthood. It’s also more common in women. However, anyone at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain may offer hope. Common antidepressants may help ease your symptoms, but there are many other options as well. Each drug used to treat depression works by balancing certain chemicals in your brain called neurotransmitters. Depression Drugs is drugs used for Depression.
Global Depression Drugs key players include Intellipharmaceutics, Pfizer, Eli Lilly, Astrazeneca, Lundbeck, etc. Global top five manufacturers hold a share over 35%.
North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share about 50%.
In terms of product, SSRIs is the largest segment, with a share over 45%. And in terms of application, the largest application is Hospitals, followed by Clinics, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Depression Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Depression Drugs.
The Depression Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Depression Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Depression Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Intellipharmaceutics
Pfizer
Eli Lilly
Astrazeneca
Lundbeck
Allergan
GSK
Otsuka Pharmaceutical
Takeda
NHU Group
Shionogi
APOTEX
Kanghong Pharma
HUAHAI
Segment by Type
SSRIs
SNRIs
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Depression Drugs in global and regional level.
Chapter 3: Detailed analysis of Depression Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Depression Drugs revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Depression Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Depression Drugs Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 SSRIs
1.2.3 SNRIs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Depression Drugs Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Depression Drugs Market Size Estimates and Forecasts
2.2 Depression Drugs Market Size by Region: 2024 Versus 2031
2.2.1 Global Depression Drugs Revenue by Region: 2020-2025
2.2.2 Global Depression Drugs Revenue Forecast by Region (2026-2031)
2.2.3 Global Depression Drugs Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Depression Drugs Revenue by Type (2020-2031)
3.1.2 Global Depression Drugs Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Depression Drugs Revenue by Application (2020-2031)
3.2.2 Global Depression Drugs Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 SSRIs of Depression Drugs Revenue Market Share by Application
3.3.2 SNRIs of Depression Drugs Revenue Market Share by Application
3.3.3 Others of Depression Drugs Revenue Market Share by Application
4 Global Depression Drugs by Company
4.1 Global Depression Drugs Revenue by Company (2020-2025)
4.2 Global Depression Drugs Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Depression Drugs Companies around the World: Ranking by Revenue
4.3.2 Global Depression Drugs Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Depression Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Depression Drugs Companies Headquarters & Product Type
4.4.1 Global Depression Drugs Companies Headquarters
4.4.2 Date of International Companies Enter into Depression Drugs Market
4.4.3 Global Depression Drugs Companies Product & Service
4.4.4 SSRIs Revenue Market Share of Depression Drugs by Company
4.4.5 SNRIs Revenue Market Share of Depression Drugs by Company
4.4.6 Others Revenue Market Share of Depression Drugs by Company
4.5 Global Depression Drugs Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Intellipharmaceutics
5.1.1 Intellipharmaceutics Corporation Information
5.1.2 Intellipharmaceutics Description, Business Overview
5.1.3 Intellipharmaceutics Depression Drugs Products Offered
5.1.4 Intellipharmaceutics Depression Drugs Revenue and Gross Margin (2020-2025)
5.1.5 Intellipharmaceutics Depression Drugs Revenue by Product in 2024
5.1.6 Intellipharmaceutics Depression Drugs Revenue by Application in 2024
5.1.7 Intellipharmaceutics Depression Drugs Revenue by Geographic Area in 2024
5.1.8 Intellipharmaceutics Recent Developments
5.2 Pfizer
5.2.1 Pfizer Corporation Information
5.2.2 Pfizer Description, Business Overview
5.2.3 Pfizer Depression Drugs Products Offered
5.2.4 Pfizer Depression Drugs Revenue and Gross Margin (2020-2025)
5.2.5 Pfizer Depression Drugs Revenue by Product in 2024
5.2.6 Pfizer Depression Drugs Revenue by Application in 2024
5.2.7 Pfizer Depression Drugs Revenue by Geographic Area in 2024
5.2.8 Pfizer Recent Developments
5.3 Eli Lilly
5.3.1 Eli Lilly Corporation Information
5.3.2 Eli Lilly Description, Business Overview
5.3.3 Eli Lilly Depression Drugs Products Offered
5.3.4 Eli Lilly Depression Drugs Revenue and Gross Margin (2020-2025)
5.3.5 Eli Lilly Depression Drugs Revenue by Product in 2024
5.3.6 Eli Lilly Depression Drugs Revenue by Application in 2024
5.3.7 Eli Lilly Depression Drugs Revenue by Geographic Area in 2024
5.3.8 Eli Lilly Recent Developments
5.4 Astrazeneca
5.4.1 Astrazeneca Corporation Information
5.4.2 Astrazeneca Description, Business Overview
5.4.3 Astrazeneca Depression Drugs Products Offered
5.4.4 Astrazeneca Depression Drugs Revenue and Gross Margin (2020-2025)
5.4.5 Astrazeneca Depression Drugs Revenue by Product in 2024
5.4.6 Astrazeneca Depression Drugs Revenue by Application in 2024
5.4.7 Astrazeneca Depression Drugs Revenue by Geographic Area in 2024
5.4.8 Astrazeneca Recent Developments
5.5 Lundbeck
5.5.1 Lundbeck Corporation Information
5.5.2 Lundbeck Description, Business Overview
5.5.3 Lundbeck Depression Drugs Products Offered
5.5.4 Lundbeck Depression Drugs Revenue and Gross Margin (2020-2025)
5.5.5 Lundbeck Depression Drugs Revenue by Product in 2024
5.5.6 Lundbeck Depression Drugs Revenue by Application in 2024
5.5.7 Lundbeck Depression Drugs Revenue by Geographic Area in 2024
5.5.8 Lundbeck Recent Developments
5.6 Allergan
5.6.1 Allergan Corporation Information
5.6.2 Allergan Description, Business Overview
5.6.3 Allergan Depression Drugs Products Offered
5.6.4 Allergan Depression Drugs Revenue and Gross Margin (2020-2025)
5.6.5 Allergan Depression Drugs Revenue by Product in 2024
5.6.6 Allergan Depression Drugs Revenue by Application in 2024
5.6.7 Allergan Depression Drugs Revenue by Geographic Area in 2024
5.6.8 Allergan Recent Developments
5.7 GSK
5.7.1 GSK Corporation Information
5.7.2 GSK Description, Business Overview
5.7.3 GSK Depression Drugs Products Offered
5.7.4 GSK Depression Drugs Revenue and Gross Margin (2020-2025)
5.7.5 GSK Depression Drugs Revenue by Product in 2024
5.7.6 GSK Depression Drugs Revenue by Application in 2024
5.7.7 GSK Depression Drugs Revenue by Geographic Area in 2024
5.7.8 GSK Recent Developments
5.8 Otsuka Pharmaceutical
5.8.1 Otsuka Pharmaceutical Corporation Information
5.8.2 Otsuka Pharmaceutical Description, Business Overview
5.8.3 Otsuka Pharmaceutical Depression Drugs Products Offered
5.8.4 Otsuka Pharmaceutical Depression Drugs Revenue and Gross Margin (2020-2025)
5.8.5 Otsuka Pharmaceutical Depression Drugs Revenue by Product in 2024
5.8.6 Otsuka Pharmaceutical Depression Drugs Revenue by Application in 2024
5.8.7 Otsuka Pharmaceutical Depression Drugs Revenue by Geographic Area in 2024
5.8.8 Otsuka Pharmaceutical Recent Developments
5.9 Takeda
5.9.1 Takeda Corporation Information
5.9.2 Takeda Description, Business Overview
5.9.3 Takeda Depression Drugs Products Offered
5.9.4 Takeda Depression Drugs Revenue and Gross Margin (2020-2025)
5.9.5 Takeda Depression Drugs Revenue by Product in 2024
5.9.6 Takeda Depression Drugs Revenue by Application in 2024
5.9.7 Takeda Depression Drugs Revenue by Geographic Area in 2024
5.9.8 Takeda Recent Developments
5.10 NHU Group
5.10.1 NHU Group Corporation Information
5.10.2 NHU Group Description, Business Overview
5.10.3 NHU Group Depression Drugs Products Offered
5.10.4 NHU Group Depression Drugs Revenue and Gross Margin (2020-2025)
5.10.5 NHU Group Depression Drugs Revenue by Product in 2024
5.10.6 NHU Group Depression Drugs Revenue by Application in 2024
5.10.7 NHU Group Depression Drugs Revenue by Geographic Area in 2024
5.10.8 NHU Group Recent Developments
5.11 Shionogi
5.11.1 Shionogi Corporation Information
5.11.2 Shionogi Description, Business Overview
5.11.3 Shionogi Depression Drugs Products Offered
5.11.4 Shionogi Depression Drugs Revenue and Gross Margin (2020-2025)
5.11.5 Shionogi Depression Drugs Revenue by Product in 2024
5.11.6 Shionogi Depression Drugs Revenue by Application in 2024
5.11.7 Shionogi Depression Drugs Revenue by Geographic Area in 2024
5.11.8 Shionogi Recent Developments
5.12 APOTEX
5.12.1 APOTEX Corporation Information
5.12.2 APOTEX Description, Business Overview
5.12.3 APOTEX Depression Drugs Products Offered
5.12.4 APOTEX Depression Drugs Revenue and Gross Margin (2020-2025)
5.12.5 APOTEX Depression Drugs Revenue by Product in 2024
5.12.6 APOTEX Depression Drugs Revenue by Application in 2024
5.12.7 APOTEX Depression Drugs Revenue by Geographic Area in 2024
5.12.8 APOTEX Recent Developments
5.13 Kanghong Pharma
5.13.1 Kanghong Pharma Corporation Information
5.13.2 Kanghong Pharma Description, Business Overview
5.13.3 Kanghong Pharma Depression Drugs Products Offered
5.13.4 Kanghong Pharma Depression Drugs Revenue and Gross Margin (2020-2025)
5.13.5 Kanghong Pharma Depression Drugs Revenue by Product in 2024
5.13.6 Kanghong Pharma Depression Drugs Revenue by Application in 2024
5.13.7 Kanghong Pharma Depression Drugs Revenue by Geographic Area in 2024
5.13.8 Kanghong Pharma Recent Developments
5.14 HUAHAI
5.14.1 HUAHAI Corporation Information
5.14.2 HUAHAI Description, Business Overview
5.14.3 HUAHAI Depression Drugs Products Offered
5.14.4 HUAHAI Depression Drugs Revenue and Gross Margin (2020-2025)
5.14.5 HUAHAI Depression Drugs Revenue by Product in 2024
5.14.6 HUAHAI Depression Drugs Revenue by Application in 2024
5.14.7 HUAHAI Depression Drugs Revenue by Geographic Area in 2024
5.14.8 HUAHAI Recent Developments
6 North America
6.1 North America Depression Drugs Market Size YoY Growth 2020-2031
6.2 North America Depression Drugs Market Facts & Figures by Country (2020-2031)
6.3 North America Depression Drugs Revenue by Type (2020-2025)
6.4 North America Depression Drugs Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Depression Drugs Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Depression Drugs Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Depression Drugs Revenue by Type (2020-2025)
7.4 Asia-Pacific Depression Drugs Revenue by Application (2020-2025)
8 Europe
8.1 Europe Depression Drugs Market Size YoY Growth 2020-2031
8.2 Europe Depression Drugs Market Facts & Figures by Country (2020-2031)
8.3 Europe Depression Drugs Revenue by Type (2020-2025)
8.4 Europe Depression Drugs Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Depression Drugs Market Size YoY Growth 2020-2031
9.2 Latin America Depression Drugs Market Facts & Figures by Country (2020-2031)
9.3 Latin America Depression Drugs Revenue by Type (2020-2025)
9.4 Latin America Depression Drugs Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Depression Drugs Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Depression Drugs Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Depression Drugs Revenue by Type (2020-2025)
10.4 Middle East and Africa Depression Drugs Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Depression Drugs Supply Chain Analysis
11.2 Depression Drugs Key Raw Materials and Upstream Suppliers
11.3 Depression Drugs Clients Analysis
11.4 Depression Drugs Sales Channel and Sales Model Analysis
11.4.1 Depression Drugs Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Depression Drugs Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Depression Drugs Distributors
12 Depression Drugs Market Dynamics
12.1 Depression Drugs Industry Trends
12.2 Depression Drugs Market Drivers
12.3 Depression Drugs Market Challenges
12.4 Depression Drugs Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Depression Drugs Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Depression Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Depression Drugs Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Depression Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Depression Drugs Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Depression Drugs Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Depression Drugs Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Depression Drugs Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Depression Drugs Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Depression Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 11. Depression Drugs Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Depression Drugs Players by Revenue (US$ Million) in 2024
Table 13. Global Depression Drugs Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Depression Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Depression Drugs as of 2024)
Table 15. Global Depression Drugs Companies Headquarters
Table 16. Date of International Companies Enter into Depression Drugs Market
Table 17. Global Depression Drugs Companies Product & Service
Table 18. Global Depression Drugs Mergers & Acquisitions, Expansion Plans
Table 19. Intellipharmaceutics Corporation Information
Table 20. Intellipharmaceutics Description and Business Overview
Table 21. Intellipharmaceutics Depression Drugs Product
Table 22. Intellipharmaceutics Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Intellipharmaceutics Revenue Proportion of Depression Drugs by Product in 2024
Table 24. Intellipharmaceutics Revenue Proportion of Depression Drugs by Application in 2024
Table 25. Intellipharmaceutics Revenue Proportion of Depression Drugs by Geographic Area in 2024
Table 26. Intellipharmaceutics Recent Developments
Table 27. Pfizer Corporation Information
Table 28. Pfizer Description and Business Overview
Table 29. Pfizer Depression Drugs Product
Table 30. Pfizer Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Pfizer Revenue Proportion of Depression Drugs by Product in 2024
Table 32. Pfizer Revenue Proportion of Depression Drugs by Application in 2024
Table 33. Pfizer Revenue Proportion of Depression Drugs by Geographic Area in 2024
Table 34. Pfizer Recent Developments
Table 35. Eli Lilly Corporation Information
Table 36. Eli Lilly Description and Business Overview
Table 37. Eli Lilly Depression Drugs Product
Table 38. Eli Lilly Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Eli Lilly Revenue Proportion of Depression Drugs by Product in 2024
Table 40. Eli Lilly Revenue Proportion of Depression Drugs by Application in 2024
Table 41. Eli Lilly Revenue Proportion of Depression Drugs by Geographic Area in 2024
Table 42. Eli Lilly Recent Developments
Table 43. Astrazeneca Corporation Information
Table 44. Astrazeneca Description and Business Overview
Table 45. Astrazeneca Depression Drugs Product
Table 46. Astrazeneca Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Astrazeneca Revenue Proportion of Depression Drugs by Product in 2024
Table 48. Astrazeneca Revenue Proportion of Depression Drugs by Application in 2024
Table 49. Astrazeneca Revenue Proportion of Depression Drugs by Geographic Area in 2024
Table 50. Astrazeneca Recent Developments
Table 51. Lundbeck Corporation Information
Table 52. Lundbeck Description and Business Overview
Table 53. Lundbeck Depression Drugs Product
Table 54. Lundbeck Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Lundbeck Revenue Proportion of Depression Drugs by Product in 2024
Table 56. Lundbeck Revenue Proportion of Depression Drugs by Application in 2024
Table 57. Lundbeck Revenue Proportion of Depression Drugs by Geographic Area in 2024
Table 58. Lundbeck Recent Developments
Table 59. Allergan Corporation Information
Table 60. Allergan Description and Business Overview
Table 61. Allergan Depression Drugs Product
Table 62. Allergan Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Allergan Revenue Proportion of Depression Drugs by Product in 2024
Table 64. Allergan Revenue Proportion of Depression Drugs by Application in 2024
Table 65. Allergan Revenue Proportion of Depression Drugs by Geographic Area in 2024
Table 66. Allergan Recent Developments
Table 67. GSK Corporation Information
Table 68. GSK Description and Business Overview
Table 69. GSK Depression Drugs Product
Table 70. GSK Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. GSK Revenue Proportion of Depression Drugs by Product in 2024
Table 72. GSK Revenue Proportion of Depression Drugs by Application in 2024
Table 73. GSK Revenue Proportion of Depression Drugs by Geographic Area in 2024
Table 74. GSK Recent Developments
Table 75. Otsuka Pharmaceutical Corporation Information
Table 76. Otsuka Pharmaceutical Description and Business Overview
Table 77. Otsuka Pharmaceutical Depression Drugs Product
Table 78. Otsuka Pharmaceutical Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Otsuka Pharmaceutical Revenue Proportion of Depression Drugs by Product in 2024
Table 80. Otsuka Pharmaceutical Revenue Proportion of Depression Drugs by Application in 2024
Table 81. Otsuka Pharmaceutical Revenue Proportion of Depression Drugs by Geographic Area in 2024
Table 82. Otsuka Pharmaceutical Recent Developments
Table 83. Takeda Corporation Information
Table 84. Takeda Description and Business Overview
Table 85. Takeda Depression Drugs Product
Table 86. Takeda Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Takeda Revenue Proportion of Depression Drugs by Product in 2024
Table 88. Takeda Revenue Proportion of Depression Drugs by Application in 2024
Table 89. Takeda Revenue Proportion of Depression Drugs by Geographic Area in 2024
Table 90. Takeda Recent Developments
Table 91. NHU Group Corporation Information
Table 92. NHU Group Description and Business Overview
Table 93. NHU Group Depression Drugs Product
Table 94. NHU Group Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. NHU Group Revenue Proportion of Depression Drugs by Product in 2024
Table 96. NHU Group Revenue Proportion of Depression Drugs by Application in 2024
Table 97. NHU Group Revenue Proportion of Depression Drugs by Geographic Area in 2024
Table 98. NHU Group Recent Developments
Table 99. Shionogi Corporation Information
Table 100. Shionogi Description and Business Overview
Table 101. Shionogi Depression Drugs Product
Table 102. Shionogi Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Shionogi Revenue Proportion of Depression Drugs by Product in 2024
Table 104. Shionogi Revenue Proportion of Depression Drugs by Application in 2024
Table 105. Shionogi Revenue Proportion of Depression Drugs by Geographic Area in 2024
Table 106. Shionogi Recent Developments
Table 107. APOTEX Corporation Information
Table 108. APOTEX Description and Business Overview
Table 109. APOTEX Depression Drugs Product
Table 110. APOTEX Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. APOTEX Revenue Proportion of Depression Drugs by Product in 2024
Table 112. APOTEX Revenue Proportion of Depression Drugs by Application in 2024
Table 113. APOTEX Revenue Proportion of Depression Drugs by Geographic Area in 2024
Table 114. APOTEX Recent Developments
Table 115. Kanghong Pharma Corporation Information
Table 116. Kanghong Pharma Description and Business Overview
Table 117. Kanghong Pharma Depression Drugs Product
Table 118. Kanghong Pharma Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Kanghong Pharma Revenue Proportion of Depression Drugs by Product in 2024
Table 120. Kanghong Pharma Revenue Proportion of Depression Drugs by Application in 2024
Table 121. Kanghong Pharma Revenue Proportion of Depression Drugs by Geographic Area in 2024
Table 122. Kanghong Pharma Recent Developments
Table 123. HUAHAI Corporation Information
Table 124. HUAHAI Description and Business Overview
Table 125. HUAHAI Depression Drugs Product
Table 126. HUAHAI Depression Drugs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 127. HUAHAI Revenue Proportion of Depression Drugs by Product in 2024
Table 128. HUAHAI Revenue Proportion of Depression Drugs by Application in 2024
Table 129. HUAHAI Revenue Proportion of Depression Drugs by Geographic Area in 2024
Table 130. HUAHAI Recent Developments
Table 131. North America Depression Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 132. North America Depression Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 133. North America Depression Drugs Revenue by Type (2020-2025) & (US$ Million)
Table 134. North America Depression Drugs Revenue by Application (2020-2025) & (US$ Million)
Table 135. Asia-Pacific Depression Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 136. Asia-Pacific Depression Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 137. Asia-Pacific Depression Drugs Revenue by Type (2020-2025) & (US$ Million)
Table 138. Asia-Pacific Depression Drugs Revenue by Application (2020-2025) & (US$ Million)
Table 139. Europe Depression Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 140. Europe Depression Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 141. Europe Depression Drugs Revenue by Type (2020-2025) & (US$ Million)
Table 142. Europe Depression Drugs Revenue by Application (2020-2025) & (US$ Million)
Table 143. Latin America Depression Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 144. Latin America Depression Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 145. Latin America Depression Drugs Revenue by Type (2020-2025) & (US$ Million)
Table 146. Latin America Depression Drugs Revenue by Application (2020-2025) & (US$ Million)
Table 147. Middle East and Africa Depression Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 148. Middle East and Africa Depression Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 149. Middle East and Africa Depression Drugs Revenue by Type (2020-2025) & (US$ Million)
Table 150. Middle East and Africa Depression Drugs Revenue by Application (2020-2025) & (US$ Million)
Table 151. Depression Drugs Key Raw Materials, Industry Status and Trend
Table 152. Depression Drugs Key Raw Materials and Upstream Suppliers
Table 153. Depression Drugs Clients Status and Trend
Table 154. Depression Drugs Typical Clients
Table 155. Depression Drugs Distributors
Table 156. Depression Drugs Market Trends
Table 157. Depression Drugs Market Drivers
Table 158. Depression Drugs Market Challenges
Table 159. Depression Drugs Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Depression Drugs Product Picture
Figure 2. Global Depression Drugs Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Depression Drugs Revenue Market Share by Type in 2024 & 2031
Figure 4. SSRIs Product Picture
Figure 5. SNRIs Product Picture
Figure 6. Others Product Picture
Figure 7. Global Depression Drugs Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Depression Drugs Revenue Market Share by Application in 2024 & 2031
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Others
Figure 12. Depression Drugs Report Years Considered
Figure 13. Global Depression Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Depression Drugs Market Size (2020-2031) & (US$ Million)
Figure 15. Global Depression Drugs Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Depression Drugs Revenue Market Share by Region (2020-2031)
Figure 17. Global Depression Drugs Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Depression Drugs Revenue Market Share Forecast by Application (2020-2031)
Figure 19. SSRIs of Depression Drugs Revenue Market Share by Application, 2024 VS 2031
Figure 20. SNRIs of Depression Drugs Revenue Market Share by Application, 2024 VS 2031
Figure 21. Others of Depression Drugs Revenue Market Share by Application, 2024 VS 2031
Figure 22. Depression Drugs Revenue Share by Company (2024)
Figure 23. Depression Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. SSRIs Revenue Proportion by Company in 2024
Figure 25. SNRIs Revenue Proportion by Company in 2024
Figure 26. Others Revenue Proportion by Company in 2024
Figure 27. North America Depression Drugs Revenue 2020-2031 (US$ Million)
Figure 28. North America Depression Drugs Revenue Market Share by Type (2020-2025)
Figure 29. North America Depression Drugs Revenue Market Share by Application (2020-2025)
Figure 30. Asia-Pacific Depression Drugs Revenue 2020-2031 (US$ Million)
Figure 31. Asia-Pacific Depression Drugs Revenue Market Share by Region (2020-2031)
Figure 32. Asia-Pacific Depression Drugs Revenue Market Share by Type (2020-2025)
Figure 33. Asia-Pacific Depression Drugs Revenue Market Share by Application (2020-2025)
Figure 34. Europe Depression Drugs Revenue Growth Rate 2020-2031 (US$ Million)
Figure 35. Europe Depression Drugs Revenue Market Share by Country (2020-2031)
Figure 36. Europe Depression Drugs Revenue Market Share by Type (2020-2025)
Figure 37. Europe Depression Drugs Revenue Market Share by Application (2020-2025)
Figure 38. Latin America Depression Drugs Revenue Growth Rate 2020-2031 (US$ Million)
Figure 39. Latin America Depression Drugs Revenue Market Share by Country (2020-2031)
Figure 40. Latin America Depression Drugs Revenue Market Share by Type (2020-2025)
Figure 41. Latin America Depression Drugs Revenue Market Share by Application (2020-2025)
Figure 42. Middle East and Africa Depression Drugs Revenue Growth Rate 2020-2031 (US$ Million)
Figure 43. Middle East and Africa Depression Drugs Revenue Market Share by Country (2020-2031)
Figure 44. Middle East and Africa Depression Drugs Revenue Market Share by Type (2020-2025)
Figure 45. Middle East and Africa Depression Drugs Revenue Market Share by Application (2020-2025)
Figure 46. Depression Drugs Supply Chain (Upstream and Downstream Market)
Figure 47. Global Production Market Share of Depression Drugs Raw Materials by Region in 2024
Figure 48. Depression Drugs Distribution Channels
Figure 49. Global Depression Drugs Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 50. Global Depression Drugs Percentage 2020-2031: Online Sales VS Offline Sales
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
